FDA
-
-
-
-
-
-
-
Appili Therapeutics announces C$750,000 private placement
-
-
-
-
-
-
-
Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference
-
-
-
-
-
-
-
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
-
-
-
-
-
-
-
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
-
-
-
-
-
-
-
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek⢠2024
-
-
-
-
-
-
-
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
-
-
-
-
-
-
-
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

